Apr 27, 2017 - Pacific Biosciences of California, Inc. (NASDAQ:PACB) Q1 2017 Results Earnings Conference Call April 26, 2017 4:30 p.m. ET Executives Trevin Rard - IR Mike Hunkapiller - Chief Executive Officer Susan
Apr 27, 2017 - The genetic-sequencing company increased revenue, but still wound up with a wider loss.
Apr 27, 2017 - Mixed first-quarter results near the top line led to a wider-than-expected first-quarter loss on the bottom line.
Apr 27, 2017 - Pacific Biosciences of California Inc. (PACB) reported a loss of 26 cents per share in the first quarter of 2017. The figure is 3 cents wider than the Zacks Consensus Estimate.
Apr 20, 2017 - Illumina is investors' best buy in this category.
Apr 17, 2017 - Pacific Biosciences of California Inc. (PACB) is scheduled to report first-quarter 2017 results on Apr 20.
Apr 16, 2017 - Have you shied away from investing in the biotech sector? Here are three key reasons why you may want to reconsider that decision.
Aug 05, 2016 - Pacific Biosciences of California Inc. (PACB) reported a loss of 21 cents per share, a penny narrower than the Zacks Consensus Estimate.
Aug 05, 2016 - Pacific Biosciences of California, Inc. (NASDAQ:PACB) Q1 2016 Earnings Conference Call August 4, 2016 04:30 PM ET Executives Trevin Rard - IR Mike Hunkapiller - CEO Susan Barnes - CFO Ben Gong - VP, F
Aug 01, 2016 - Pacific Biosciences of California Inc. (PACB) is scheduled to report second-quarter 2016 results on Aug 4.